摘要
阿尔茨海默病(AD)是一种神经退行性疾病,其中的β-淀粉样蛋白(Aβ)肽在突触功能障碍和记忆减退的神经功能障碍和tau蛋白过度磷酸化神经细胞内积累相关的关键作用。两个新的对映异构体大黄酸huprine((+)- 1(–)1)混合物具有较强的对人乙酰胆碱酯酶(AChE)、丁酰胆碱酯酶(BuChE),和BACE-1的抑制作用以及β-淀粉样蛋白和tau蛋白体外抗血小板聚集活性降低,体内淀粉样前体蛋白(APP)降低。有趣的是,在这项工作中,我们都观察到了有益的作用(+)-和(–)- 1在一个AβPPswe/PS-1阿尔茨海默´模型提出的神经病理学的逆转,包括在β-淀粉样蛋白水平降低,tau蛋白磷酸化和记忆障碍与治疗。同时,在年轻的转基因小鼠出现早期症状突触失败和丧失记忆,我们找到了一个保护认知功能,包括长时程增强(LTP)和减少神经炎症的(+)-和(–)- 1。此外,与先进的疾病的动物(11个月大)呈现只有与右旋对映体逆转的加剧的神经退行性疾病。这些研究表明,大黄酸huprine衍生物具有可能具有治疗阿尔茨海默病潜力的多重属性。
关键词: 阿尔茨海默病动物模型,β-淀粉样蛋白肽,tau蛋白,大黄酸huprine衍生物,长时程增强,记忆。
Current Alzheimer Research
Title:Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages
Volume: 13 Issue: 9
Author(s): Felipe G. Serrano, Cheril Tapia-Rojas, Francisco J. Carvajal, Pedro Cisternas, Elisabet Viayna, Irene Sola, Diego Munoz-Torrero and Nibaldo C. Inestrosa
Affiliation:
关键词: 阿尔茨海默病动物模型,β-淀粉样蛋白肽,tau蛋白,大黄酸huprine衍生物,长时程增强,记忆。
摘要: Alzheimer’s disease (AD) is a neurodegenerative disorder in which the amyloid-β (Aβ) peptide plays a key role in synaptic impairment and memory decline associated with neuronal dysfunction and intra-neuronal accumulation of hyperphosphorylated tau protein. Two novel enantiopure rhein-huprine hybrids ((+)-1 and (–)-1) exhibit potent inhibitory effects against human acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), BACE-1 and both Aβ and tau antiaggregation activity in vitro and reduction on the amyloid precursor protein (APP) processing in vivo. Interestingly, in this work, we observed beneficial effects with both (+)- and (–)-1 in the reversion of the neuropathology presented in the AβPPswe/PS-1 Alzheimer´s model, including a reduction in the Aβ levels, tau phosphorylation and memory impairment with both treatments. Also, in young transgenic mice that present early symptoms of synaptic failure and memory loss, we found a protection of cognitive functions, including long-term potentiation (LTP) and a reduction of the neuro-inflammation by both (+)- and (–)-1. Furthermore, animals with an advanced disease (11month-old) present an exacerbate neurodegeneration that is reversed only with the dextrorotatory enantiomer. These studies indicated that rhein-huprine derivatives with multiple properties might have interesting therapeutic potential for AD.
Export Options
About this article
Cite this article as:
Felipe G. Serrano, Cheril Tapia-Rojas, Francisco J. Carvajal, Pedro Cisternas, Elisabet Viayna, Irene Sola, Diego Munoz-Torrero and Nibaldo C. Inestrosa , Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages, Current Alzheimer Research 2016; 13 (9) . https://dx.doi.org/10.2174/1567205012666151027141542
DOI https://dx.doi.org/10.2174/1567205012666151027141542 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Linking New Paradigms in Protein Chemistry to Reversible Membrane-Protein Interactions
Current Protein & Peptide Science Biological Markers in Older People at Risk of Mobility Limitations
Current Pharmaceutical Design Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease
Current Neuropharmacology Experimental Approaches to Tse Prevention Via Inhibition of Prion Formation
Protein & Peptide Letters Hypoxia, Lead Toxicities and Oxidative Stress: Cell Signaling, Molecular Interactions and Antioxidant (Vitamin C) Defense
Current Signal Transduction Therapy Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies
Current Aging Science Aging and DNA Methylation
Current Chemical Biology Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer’s Disease Therapy
Current Topics in Medicinal Chemistry Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies
Current Pharmaceutical Biotechnology Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs
Current Medicinal Chemistry The Role of Platelets and their Microparticles in Rehabilitation of Ischemic Brain Tissue
CNS & Neurological Disorders - Drug Targets Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
CNS & Neurological Disorders - Drug Targets Editorial (Hot Topic: Epidemiology & Risk Factors for Alzheimer’s Disease)
Current Alzheimer Research Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems
Current HIV Research How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research “Care-Getting”: A Conceptual Model of Marshalling Support Near the End of Life
Current Aging Science Routine Collection of Patient-Reported Outcomes in an HIV Clinic Setting:The First 100 Patients
Current HIV Research Delineating Somatostatins Neuronal Actions
Current Drug Targets - CNS & Neurological Disorders